239 related articles for article (PubMed ID: 27927781)
1. Genetic Variants Associated with Circulating Parathyroid Hormone.
Robinson-Cohen C; Lutsey PL; Kleber ME; Nielson CM; Mitchell BD; Bis JC; Eny KM; Portas L; Eriksson J; Lorentzon M; Koller DL; Milaneschi Y; Teumer A; Pilz S; Nethander M; Selvin E; Tang W; Weng LC; Wong HS; Lai D; Peacock M; Hannemann A; Völker U; Homuth G; Nauk M; Murgia F; Pattee JW; Orwoll E; Zmuda JM; Riancho JA; Wolf M; Williams F; Penninx B; Econs MJ; Ryan KA; Ohlsson C; Paterson AD; Psaty BM; Siscovick DS; Rotter JI; Pirastu M; Streeten E; März W; Fox C; Coresh J; Wallaschofski H; Pankow JS; de Boer IH; Kestenbaum B
J Am Soc Nephrol; 2017 May; 28(5):1553-1565. PubMed ID: 27927781
[TBL] [Abstract][Full Text] [Related]
2. Association of pulse wave velocity with single nucleotide polymorphisms related to parathyroid hormone.
Cheng YB; Guo QH; Zhang DY; Wang Y; Huang QF; Sheng CS; Wang JG; Staessen JA; Li Y
Blood Press; 2018 Aug; 27(4):222-230. PubMed ID: 29504807
[TBL] [Abstract][Full Text] [Related]
3. Genetic Variants Associated with Circulating Fibroblast Growth Factor 23.
Robinson-Cohen C; Bartz TM; Lai D; Ikizler TA; Peacock M; Imel EA; Michos ED; Foroud TM; Akesson K; Taylor KD; Malmgren L; Matsushita K; Nethander M; Eriksson J; Ohlsson C; Mellström D; Wolf M; Ljunggren O; McGuigan F; Rotter JI; Karlsson M; Econs MJ; Ix JH; Lutsey PL; Psaty BM; de Boer IH; Kestenbaum BR
J Am Soc Nephrol; 2018 Oct; 29(10):2583-2592. PubMed ID: 30217807
[TBL] [Abstract][Full Text] [Related]
4. Genetic Variants Associated With Mineral Metabolism Traits in Chronic Kidney Disease.
Laster ML; Rowan B; Chen HC; Schwantes-An TH; Sheng X; Friedman PA; Ikizler TA; Sinshiemer JS; Ix JH; Susztak K; de Boer IH; Kestenbaum B; Hung A; Moe SM; Perwad F; Robinson-Cohen C
J Clin Endocrinol Metab; 2022 Aug; 107(9):e3866-e3876. PubMed ID: 35587600
[TBL] [Abstract][Full Text] [Related]
5. Association between promoter region genetic variants of PTH SNPs and serum 25(OH)-vitamin D level.
Al-Daghri NM; Al-Attas OS; Krishnaswamy S; Yakout SM; Mohammed AK; Alenad AM; Chrousos GP; Alokail MS
Int J Clin Exp Pathol; 2015; 8(7):8463-71. PubMed ID: 26339419
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide meta-analysis identifies novel loci associated with parathyroid hormone level.
Matana A; Brdar D; Torlak V; Boutin T; Popović M; Gunjača I; Kolčić I; Boraska Perica V; Punda A; Polašek O; Barbalić M; Hayward C; Zemunik T
Mol Med; 2018 Apr; 24(1):15. PubMed ID: 30134803
[TBL] [Abstract][Full Text] [Related]
7. Effects of genetic variants on serum parathyroid hormone in hyperparathyroidism and end-stage renal disease patients: A systematic review and meta-analysis.
Matana A; Popović M; Torlak V; Punda A; Barbalić M; Zemunik T
Medicine (Baltimore); 2018 May; 97(21):e10834. PubMed ID: 29794776
[TBL] [Abstract][Full Text] [Related]
8. IL21R and PTH may underlie variation of femoral neck bone mineral density as revealed by a genome-wide association study.
Guo Y; Zhang LS; Yang TL; Tian Q; Xiong DH; Pei YF; Deng HW
J Bone Miner Res; 2010 May; 25(5):1042-8. PubMed ID: 19874204
[TBL] [Abstract][Full Text] [Related]
9. Calcium-Sensing Receptor Genotype and Response to Cinacalcet in Patients Undergoing Hemodialysis.
Moe SM; Wetherill L; Decker BS; Lai D; Abdalla S; Long J; Vatta M; Foroud TM; Chertow GM
Clin J Am Soc Nephrol; 2017 Jul; 12(7):1128-1138. PubMed ID: 28630081
[TBL] [Abstract][Full Text] [Related]
10. A prospective study of plasma 25-hydroxyvitamin D concentration and prostate cancer risk.
Deschasaux M; Souberbielle JC; Latino-Martel P; Sutton A; Charnaux N; Druesne-Pecollo N; Galan P; Hercberg S; Le Clerc S; Kesse-Guyot E; Ezzedine K; Touvier M
Br J Nutr; 2016 Jan; 115(2):305-14. PubMed ID: 26568368
[TBL] [Abstract][Full Text] [Related]
11. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
12. Associations between single nucleotide polymorphisms in the calcium sensing receptor and chronic kidney disease-mineral and bone disorder in cats.
Geddes RF; Jepson RE; Forcada Y; Elliott J; Syme HM
Vet J; 2018 May; 235():34-41. PubMed ID: 29704936
[TBL] [Abstract][Full Text] [Related]
13. Genetic variation in the PTH pathway and bone phenotypes in elderly women: evaluation of PTH, PTHLH, PTHR1 and PTHR2 genes.
Tenne M; McGuigan F; Jansson L; Gerdhem P; Obrant KJ; Luthman H; Akesson K
Bone; 2008 Apr; 42(4):719-27. PubMed ID: 18280230
[TBL] [Abstract][Full Text] [Related]
14. Evidence that serum phosphate is independently associated with serum PTH in patients with chronic renal failure.
Kates DM; Sherrard DJ; Andress DL
Am J Kidney Dis; 1997 Dec; 30(6):809-13. PubMed ID: 9398125
[TBL] [Abstract][Full Text] [Related]
15. Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent risk factors?
Anderson JL; Vanwoerkom RC; Horne BD; Bair TL; May HT; Lappé DL; Muhlestein JB
Am Heart J; 2011 Aug; 162(2):331-339.e2. PubMed ID: 21835295
[TBL] [Abstract][Full Text] [Related]
16. Contribution of the putative genetic factors and ANKH gene polymorphisms to variation of circulating calciotropic molecules, PTH and BGP.
Vistoropsky Y; Keter M; Malkin I; Trofimov S; Kobyliansky E; Livshits G
Hum Mol Genet; 2007 May; 16(10):1233-40. PubMed ID: 17403715
[TBL] [Abstract][Full Text] [Related]
17. Associations of vitamin D receptor, calcium-sensing receptor and parathyroid hormone gene polymorphisms with calcium homeostasis and peripheral bone density in adult Finns.
Laaksonen MM; Outila TA; Karkkainen MU; Kemi VE; Rita HJ; Perola M; Valsta LM; Lamberg-Allardt CJ
J Nutrigenet Nutrigenomics; 2009; 2(2):55-63. PubMed ID: 19690432
[TBL] [Abstract][Full Text] [Related]
18. Parathyroid Hormone and Bone Mineral Density: A Mendelian Randomization Study.
Qu Z; Yang F; Hong J; Wang W; Yan S
J Clin Endocrinol Metab; 2020 Nov; 105(11):. PubMed ID: 32827441
[TBL] [Abstract][Full Text] [Related]
19. Sex and age modify biochemical and skeletal manifestations of chronic hyperparathyroidism by altering target organ responses to Ca2+ and parathyroid hormone in mice.
Cheng Z; Liang N; Chen TH; Li A; Santa Maria C; You M; Ho H; Song F; Bikle D; Tu C; Shoback D; Chang W
J Bone Miner Res; 2013 May; 28(5):1087-100. PubMed ID: 23239173
[TBL] [Abstract][Full Text] [Related]
20. Plasma parathyroid hormone and the risk of cardiovascular mortality in the community.
Hagström E; Hellman P; Larsson TE; Ingelsson E; Berglund L; Sundström J; Melhus H; Held C; Lind L; Michaëlsson K; Arnlöv J
Circulation; 2009 Jun; 119(21):2765-71. PubMed ID: 19451355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
